IDBS

🗞️ In the November issue of our newsletter, we shared Craig Williamson PhD’s five-stage guide to digital maturity as he stressed the need for future proofing enterprise data. The newsletter also featured Unjulie Bhanot's latest blog which explains why ensuring your data adheres to FAIR data principals is essential for the successful adoption of #AI. Read the November issue in full below: https://ow.ly/egIc50Uv42M #digitaltransformation #digitalmaturity

🤖 Are you #AI-ready? Read Dave Watrous’ article in Drug Development & Delivery for a roadmap to AI adoption: https://ow.ly/1WLo50Uoayf Dave suggests that employees across all levels, from decision-makers to end-users, need to fully understand the capabilities of AI and their role in its adoption. What are your top tips for the introduction and roll-out of AI? Let us know in the comments. #lifesciences #labofthefuture #DanaherNews

While LIMS and ELNs have reliably served the #biopharma industry for many years, rapid development in this industry means that a more streamlined platform to support the entire development lifecycle is now required. 🚪 Enter IDBS Polar: a powerful, cloud-based software platform that manages data across every stage of the product lifecycle, from discovery all the way through to development. Book a demo to learn how you can save 7.5 hours a week going paperless with IDBS Polar*: https://ow.ly/o9Oh50UtkGV #datamanagement #drugdiscovery *E-WorkBook customer data on file at IDBS. Polar has like-for-like implementation as E-WorkBook. IDBS Polar delivers the same or higher gains as IDBS E-Workbook in a like-for-like implementation, with added value from advanced analytics, AI/ML and reporting.

Happy Holidays from the IDBS Team! As the year comes to a close, we want to take a moment to express our heartfelt gratitude to our incredible clients, partners and colleagues. Your continuous support and collaboration have been instrumental in our shared success, and we’re excited to see what we can achieve together in the coming year. 2024 has been a year of innovation, growth and breakthroughs. From advancing our research data management solutions to fostering stronger partnerships, we’re proud of the strides we’ve made and the impact we’ve created in the scientific community. As we celebrate this festive season, we wish you and your loved ones joy, health and prosperity. Here’s to a bright and promising 2025, filled with new opportunities and continued success! Warmest wishes, The IDBS Team

The biopharmaceutical industry is increasingly focused on sustainability. However, traditional drug discovery and development processes are often lengthy, inefficient and wasteful. 🌳To support this, digital solutions like IDBS Polar can help streamline workflows, reduce resource consumption and accelerate time-to-market. By leveraging IDBS' advanced analytics capabilities, and experiment-linked tools such as Design of Experiments (DoE) and Multivariate Analysis (MVA), scientists can optimize processes, minimize errors and reduce waste. Read more in Chris Ovett's article on pharmaphorum: https://ow.ly/UJ6O50UqLZu #biopharma #drugdiscovery #sustainability #digitaltransformation #DanaherNews

🤔 Considering a move to an automated data management system? In an interview with BioPharm International, Nathalie Batoux outlines the key advantages of digitalization, including: ✅ Greater data context ✅ Traceability ✅ Accessibility ✅ Reproducibility Read the article for Nathalie’s tips on maintaining data integrity: https://ow.ly/ZnuQ50UoarK #dataintegrity #biopharma #DanaherNews

Missed Craig Williamson PhD's blog on the transformational impact of a digital backbone? 🦴 Read it here: https://ow.ly/FmNz50Uoa9h According to a 2023 PwC survey, 89% of companies are increasing their overall technology budget to unlock returns by implementing a scalable digital backbone. Craig agrees with this strategy, citing Unjulie Bhanot’s comments in a recent Technology Networks article (link in the comments): 💬 A digital backbone, Unjulie explains, “realizes the full potential of data and generates meaningful insights.” #digitalstrategy #biotechnology

👀 Looking to improve the efficiency of your #pharma lab? Vectura Group, a specialist innovation CDMO, had been facing data management challenges due to its paper-based system. They transitioned to a cloud-based IDBS solution which offers greater reliability and has ensured that lab downtime is at a minimum. 📈 David Thomas, Project Lead at Vectura, explained that he has seen a significant improvement in productivity, allowing Vectura “to spend less resource on compliance and speed up the process.” Read the case study to learn more about how IDBS solutions have boosted efficiency: https://ow.ly/QzQF50UqMUK #digitaltransformation #drugdiscovery

💵 According to Rockwell Automation, a single tech transfer event costs anywhere between $5 million and $40 million. Deficiencies in the level of digitalization can significantly impact the tech transfer process, leading to delays, inefficiencies and compromised product quality. A high level of digital maturity can help to ensure that tech transfers run smoothly, and money is not wasted. Enhance your digital maturity with one of our tailored solutions: https://ow.ly/mTZg50Uo7vu How digitally mature is your lab? Let us know in the comments. #biotechnology #digitalmaturity

According to industry estimates, approximately 85% of biomedical research is wasted due to inefficiencies, causing delays and overuse of precious resources. Chris Ovett, Head of Business Development & Open Innovation, discusses with pharmaphorum why it's vital to use structured statistical methods and robust digital tools to minimize waste and make drug discovery more efficient and sustainable: https://ow.ly/tWJQ50UquWR #DanaherNews #Sustainability #IDBS